A group from Fujita Health University has identified the first known case of posterior reversible encephaliopathy syndrome (PRES) associated with HHV-6B encephalitis.
New study shows that HHV-6 encephalitis leads to very poor outcome
New study shows that patients who develop HHV-6 encephalitis have a significantly poor prognosis
Study finds nearly 10% of cord blood transplant patients develop HHV-6 encephalitis
International group calls for routine HHV-6 surveillance in all cases of UCBT
HHV-6 causes limbic encephalitis in 10% of cord blood transplant patients.
New study from Harvard finds heightened risk of HHV-6 PALE for UCBT patients.
Epilepsy Following HHV-6 Limbic Encephalitis in Pediatric Transplant Patients
A group from the Royal Children’s Hospital in Melbourne, Australia has reported the development of epilepsy after HHV-6 posttransplant limbic encephalitis (PALE) among children receiving stem cell transplantation with cord blood (CBT).